within Pharmacolibrary.Drugs.ATC.S;

model S01ED52
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.007,
    adminDuration  = 600,
    adminMass      = 0.005,
    adminCount     = 1,
    Vd             = 0.006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Betaxolol is a selective beta-1 adrenergic receptor blocker used primarily for the treatment of elevated intraocular pressure in conditions such as glaucoma and ocular hypertension. As part of combinations classified under ATC S01ED52, it is used topically in ophthalmology, usually in formulations combined with other agents. Betaxolol is approved for clinical use, particularly in the form of eye drops.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are not directly reported in literature for betaxolol combinations used in ophthalmic formulations (ATC S01ED52). Parameters below are estimated based on typical topical ophthalmic beta blocker properties and pharmacokinetics reported for single-agent betaxolol in adults.</p><h4>References</h4><ol><li>Anam Fayyaz, Kati-Sisko Vellonen, Veli-Pekka Ranta, Elisa Toropainen, Mika Reinisalo, Annika Valtari, Jooseppi Puranen, Giuseppe D'Amico Ricci, Emma M Heikkinen, Iain Gardner, Marika Ruponen, Arto Urtti, Masoud Jamei, Eva M Del Amo,Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: Tissue exposures in the rabbit eye.,European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,2021<a href='https://pubmed.ncbi.nlm.nih.gov/34139290/'>https://pubmed.ncbi.nlm.nih.gov/34139290/</a></li><li>Anam Fayyaz, Veli-Pekka Ranta, Elisa Toropainen, Kati-Sisko Vellonen, Giuseppe D'Amico Ricci, Mika Reinisalo, Emma M Heikkinen, Iain Gardner, Arto Urtti, Masoud Jamei, Eva M Del Amo,Ocular Intracameral Pharmacokinetics for a Cocktail of Timolol, Betaxolol, and Atenolol in Rabbits.,Molecular pharmaceutics,2020<a href='https://pubmed.ncbi.nlm.nih.gov/31794668/'>https://pubmed.ncbi.nlm.nih.gov/31794668/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01ED52;
